Endodoc

When the ground-breaking Diabetes Control and Complications Trial, or “DCCT,” results were reported in 1993, for the first time, specific goals for glycemic control in patients with diabetes were recommended…

The other day I saw a patient with type 1 diabetes who had switched from a multiple injection regimen using  glargine (Lantus brand) and lispro (Humalog brand)  to one with…